Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Non-comparative Study To Evaluate Parasitological Clearance Rates And Pharmacokinetics Of Azithromycin And Chloroquine Following Administration Of A Fixed Dose Combination Of Azithromycin And Chloroquine (Azcq) In Asymptomatic Pregnant Women With Plasmodium Falciparum Parasitemia In Sub-saharan Africa

NCT01103713 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01103713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01103713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Non-comparative Study To Evaluate Parasitological Clearance Rates And Pharmacokinetics Of Azithromycin And Chloroquine Following Administration Of A Fixed Dose Combination Of Azithromycin And Chloroquine (Azcq) In Asymptomatic Pregnant Women With Plasmodium Falciparum Parasitemia In Sub-saharan Africa
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Terminated
Start date
March 31, 2011
Completion date
October 31, 2013
Enrollment
168 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

asymptomatic parasitemia in pregnancy